By Jeff Montgomery ( February 8, 2016, 8:56 PM EST) -- An Akrimax Pharmaceuticals LLC investor lost a bid Monday for a preliminary injunction freezing the status of the company and a drug license allegedly in play for $250 million or more, with a Delaware vice chancellor suggesting a damages settlement as a simpler solution to an ongoing fraud and conspiracy lawsuit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.